Global Parenteral Nutrition Markets, 2016-2018 & 2024 - Rising Number of Premature Births Enhances Need for Parenteral Nutrition

DUBLIN, June 22, 2018 /PRNewswire/ --

The "Parenteral Nutrition - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Parenteral Nutrition in US$ Million

The report profiles 20 companies including many key and niche players such as:

• Allergan plc (Ireland)
• Amanta Healthcare Ltd (India)
• B. Braun Melsungen AG (Germany)
• Baxter International, Inc. (USA)
• Fresenius KABI AG (Germany)
• Grifols International S.A. (Spain)
• ICU Medical, Inc. (USA)
• Otsuka Pharmaceutical Factory, Inc. (Japan)
• Sichuan Kelun Pharmaceutical Co., Ltd. (China)
• Sino-Swed Pharmaceutical Corp. Ltd. (China)

Key Topics Covered: 

1. INDUSTRY OVERVIEW
Parenteral Nutrition: Providing Essential Nutrition through Intravenous Feeding
Malnutrition Related to Chronic Medical Conditions Fuels Demand for PN Products
The Road Ahead
Developed Economies Lead, Developing Regions to Propel Future Growth
Single Dose Amino Acid Solutions
Major Share of PN Solutions Market
Competitive Landscape
Leading Players in the Global Parenteral Nutrition Market (2017E): Percentage Breakdown of Revenues for B. Braun, Baxter, Fresenius, ICU Medical and Others (includes corresponding Graph/Chart)

2. MARKET TRENDS, DRIVERS & ISSUES
Clinical Nutrition Vital for Combating Malnutrition during Hospitalization
Increase in Healthcare Spending Bodes Well for Parenteral Nutrition Market
Rapidly Aging Demographics to Propel Demand for Parenteral Nutrition
Rising Incidence of Chronic Diseases to Propel Growth of Parenteral Nutrition Market
Cancer Patients - the Highest PN Users
Parenteral Nutrition: Critical for People with Gastrointestinal Disorders
Unrelenting Threat of HIV/AIDS Infection: An Opportunity for Parenteral Nutrition Market
Diabetes Mellitus: PN Therapy Indicated for Patients with Non-functional GI Tract
Global Diabetic Statistics
Opportunity Indicators
Rising Number of Premature Births Enhances Need for Parenteral Nutrition
Preterm Birth Statistics from WHO
Inadequate Physiological Development Raises Need for Tube Feeding in Infants
Nutritional Needs of Premature Infants: Mix of PN & EN Nutrition Emerges as Common Practice
Intravenous Therapy in Outpatient Settings to Boost Parenteral Nutrition Market
Growing Demand for Home Intravenous Nutritional Therapies
Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
Pre-mixed IV Nutrition: A Step towards Safer Medication Practices
Growing Demand for Low-Cost Parenteral Nutrition Solutions
Rising Popularity of Intravenous Vitamin C for Cancer Treatment
Increasing Demand for Peripheral Intravenous Nutrition
Iron Replacement Therapies
A Potential Market Segment
Popularity of TPN as Beauty Treatment Raises Ethical and Safety Concerns
Pharmaceutical Industry Participants Migrate from Concentrated Vials to Premixed Solutions
Vial Dilution and Potential Risks
Premixed Bags Present Efficient Delivery System
Switching from Vials to Premixed Bags
Challenges Confronting Production of Parenteral Products
Continuous Supply of Raw Material: Crucial for Production
Rising Preference for Enteral Nutrition: A Threat to Parenteral Nutrition Market
Infection Control: A Prime Concern in Parenteral Nutrition
Limiting Medication Errors
A Key Concern

3. PRODUCT INNOVATIONS/INTRODUCTIONS
Baxter Introduces OLIMEL Emulsion for Parenteral Nutrition
Baxter Introduces NUMETA G13%E Preterm 300 mL for Preterm New- borns
B. Braun Unveils Parenteral Nutrition 360 (PN360) Program
Baxter Introduces NUMETA G13E 300 mL in Europe
Fresenius Kabi Introduces Smoflipid Intravenous Fat Emulsion
Amanta Healthcare Introduces SteriPort IV Fluid System
B. Braun Medical Unveils Clinical Nutrition 360

4. RECENT INDUSTRY ACTIVITY
Otsuka OPV to Build New Factory for Distribution of IV Solutions
ASPEN Collaborates with Baxter for PN Therapy
Grifols Gains FDA Clearance for Physiological Saline Solution
Otsuka to Acquire Complete Stake in Otsuka Pharmaceutical India
ICU Medical Takes Over Hospira Infusion Systems Business from Pfizer
Baxter Acquires Claris Injectables
Amanta Healthcare Invests for Development of SteriPort
Pfizer Acquires Hospira
Baxter and Laboratoire Aguettant Collaborate for PN Trace Elements
Actavis Takes Over Allergan

5. FOCUS ON SELECT GLOBAL PLAYERS

6. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 20 (including Divisions/Subsidiaries 27)

• The United States (6)
• Japan (2)
• Europe (9)
• France (1)
• Germany (3)
• The United Kingdom (1)
• Spain (1)
• Rest of Europe (3)
• Asia-Pacific (Excluding Japan) (9)
• Africa (1)

For more information about this report visit https://www.researchandmarkets.com/research/9882qv/global_parenteral?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com